Live Breaking News & Updates on Catalent company details

Stay informed with the latest breaking news from Catalent company details on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Catalent company details and stay connected to the pulse of your community

Catalent, Inc. (NYSE:CTLT) Receives $52.46 Average Price Target from Analysts

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have earned an average recommendation of “Hold” from the thirteen brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

Blackrock , Nova-scotia , Canada , Consumer-health , Barclays , Blackrock-inc , Catalent-company-profile , Nomura-holdings-inc , Vanguard-group-inc , Pricet-rowe-associates-inc , Catalent-inc

Gladius Capital Management LP Invests $28,000 in Catalent, Inc. (NYSE:CTLT)

Gladius Capital Management LP bought a new position in shares of Catalent, Inc. (NYSE:CTLT – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 614 shares of the company’s stock, valued at approximately $28,000. A number of other institutional investors also recently […]

Canada , Robertw-baird , Wells-fargo-company , Royal-bank , Catalent-inc , Partners-investment-advisory , Securities-exchange-commission , Covestor-ltd , Jefferies-financial-group-inc , Consumer-health , Kb-financial-partners

OMERS ADMINISTRATION Corp Sells 108,279 Shares of Catalent, Inc. (NYSE:CTLT)

OMERS ADMINISTRATION Corp trimmed its position in Catalent, Inc. (NYSE:CTLT – Free Report) by 41.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,964 shares of the company’s stock after selling 108,279 shares during the quarter. OMERS ADMINISTRATION […]

Robertw-baird , William-blair , Catalent-inc , Exchange-commission , Consumer-health , Barclays , Exchange-traded-concepts , Partners-investment-advisory , Catalent-company-profile , Jefferies-financial-group-inc , Kb-financial-partners , Free-report

Catalent (NYSE:CTLT) Posts Earnings Results, Misses Expectations By $0.22 EPS

Catalent (NYSE:CTLT – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.22), MarketWatch Earnings reports. The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.01 billion. Catalent had a […]

Canada , William-blair , Barclays-plc , Catalent-inc , Norges-bank , Ameriprise-financial-inc , Barclays , Catalent-company-profile , Royal-bank , Consumer-health , Morgan-stanley , Wells-fargo-company

Catalent (NYSE:CTLT) Releases Earnings Results, Misses Estimates By $0.22 EPS

Catalent (NYSE:CTLT – Get Free Report) released its earnings results on Friday. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.22), MarketWatch Earnings reports. Catalent had a negative net margin of 22.36% and a positive return on equity of 1.55%. The business had revenue of $1.03 billion for […]

Robertw-baird , Kb-financial-partners , Wells-fargo-company , Catalent-inc , Consumer-health , Jefferies-financial-group-inc , Barclays , Catalent-company-profile , Covestor-ltd , Qube-research-technologies-ltd , Tower-research-capital

Catalent's (CTLT) Neutral Rating Reiterated at UBS Group

UBS Group reaffirmed their neutral rating on shares of Catalent (NYSE:CTLT – Free Report) in a report published on Tuesday, Benzinga reports. The firm currently has a $63.50 price target on the stock, up from their previous price target of $58.00. A number of other research analysts have also issued reports on the company. Royal […]

Canada , William-blair , Barclays , Royal-bank , Consumer-health , Cetera-advisor-networks , Advisor-group , Dimensional-fund-advisors , Panagora-asset-management-inc , Yousif-capital-management , Wells-fargo-company , Catalent-company-profile

Royal Bank of Canada Reaffirms Sector Perform Rating for Catalent (NYSE:CTLT)

Royal Bank of Canada reaffirmed their sector perform rating on shares of Catalent (NYSE:CTLT – Free Report) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $63.50 price target on the stock, up from their prior price target of $58.00. CTLT has been the subject of several other reports. […]

Canada , William-blair , Robertw-baird , Dimensional-fund-advisors , Barclays , Consumer-health , Advisor-group , Cetera-advisor-networks , Royal-bank , Catalent-inc , Yousif-capital-management , Panagora-asset-management-inc

Catalent Swings to 2Q Loss on Lower Sales After Covid Programs Fade

By Dean Seal Catalent swung to a loss in its fiscal second quarter as sales fell and margins weakened. The contract drug manufacturer posted a loss of $204...

Novo-nordisk , Dean-seal , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Specialized-drugs-medications , Financial-performance , Earnings , Sales-figures , Corporate-industrial-news , Content-types

Catalent Posts Wider-than-expected Q2 Loss; Revenues Down

Catalent, Inc. (CTLT) reported Friday that its second-quarter net loss was $204 million or $1.12 per share, compared to last year's net earnings of $81 million or $0.

Catalent-inc , Thomson-reuters , Catalent , Atalent-earnings ,